217 related articles for article (PubMed ID: 31233564)
21. Endothelin-induced contraction of the portal vein in cirrhosis.
Petrowsky H; Schmandra T; Lorey T; Hanisch E; Herrmann G
Eur Surg Res; 1999; 31(3):289-96. PubMed ID: 10352358
[TBL] [Abstract][Full Text] [Related]
22. The potential of cerium oxide nanoparticles (nanoceria) for neurodegenerative disease therapy.
Estevez AY; Erlichman JS
Nanomedicine (Lond); 2014 Jul; 9(10):1437-40. PubMed ID: 25253491
[No Abstract] [Full Text] [Related]
23. Polyphenol-Rich Blackcurrant Juice Prevents Endothelial Dysfunction in the Mesenteric Artery of Cirrhotic Rats with Portal Hypertension: Role of Oxidative Stress and the Angiotensin System.
Rashid S; Idris-Khodja N; Auger C; Kevers C; Pincemail J; Alhosin M; Boehm N; Oswald-Mammosser M; Schini-Kerth VB
J Med Food; 2018 Apr; 21(4):390-399. PubMed ID: 29569976
[TBL] [Abstract][Full Text] [Related]
24. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
26. [Differences of nitric oxide synthase expression and activity between splanchnic arterial and venous vessels of cirrhotic rats].
Yu J; Liang K; Tian D; Wang T; Tang W; Zhang W; Liu M
Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):352-4. PubMed ID: 11782304
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
28. [Akt gene therapy for cirrhotic rats with portal hypertension].
Huang FZ; Deng G; Liu XY; Luo CQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
[TBL] [Abstract][Full Text] [Related]
29. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
30. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
31. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.
Poo JL; Jiménez W; María Muñoz R; Bosch-Marcé M; Bordas N; Morales-Ruiz M; Pérez M; Deulofeu R; Solé M; Arroyo V; Rodés J
Gastroenterology; 1999 Jan; 116(1):161-7. PubMed ID: 9869614
[TBL] [Abstract][Full Text] [Related]
32. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
Feng H; Leng X; Zhang Z
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system.
Rubio L; Annangi B; Vila L; Hernández A; Marcos R
Arch Toxicol; 2016 Feb; 90(2):269-78. PubMed ID: 25618551
[TBL] [Abstract][Full Text] [Related]
34. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
Rockey DC; Chung JJ
Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
[TBL] [Abstract][Full Text] [Related]
35. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis.
Tazi KA; Barrière E; Moreau R; Heller J; Sogni P; Pateron D; Poirel O; Lebrec D
Gastroenterology; 2002 Jun; 122(7):1869-77. PubMed ID: 12055594
[TBL] [Abstract][Full Text] [Related]
36. Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.
Bolognesi M; Zampieri F; Di Pascoli M; Verardo A; Turato C; Calabrese F; Lunardi F; Pontisso P; Angeli P; Merkel C; Gatta A; Sacerdoti D
Liver Int; 2011 Jul; 31(6):881-90. PubMed ID: 21645220
[TBL] [Abstract][Full Text] [Related]
37. Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats.
Hernández-Muñoz R; Díaz-Muñoz M; Suárez-Cuenca JA; Trejo-Solís C; López V; Sánchez-Sevilla L; Yáñez L; De Sánchez VC
Hepatology; 2001 Oct; 34(4 Pt 1):677-87. PubMed ID: 11584363
[TBL] [Abstract][Full Text] [Related]
38. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
Thabut D; Tazi KA; Bonnefont-Rousselot D; Aller M; Farges O; Guimont MC; Tellier Z; Guichard C; Ogier-Denis E; Poynard T; Moreau R; Lebrec D
Hepatology; 2007 Dec; 46(6):1893-906. PubMed ID: 17918268
[TBL] [Abstract][Full Text] [Related]
40. Peculiarities of ultrastructural organization and metabolism of reactive forms of oxygen and nitrogen in a cardiovascular system for permanent effects of ionizing radiation in low doses.
Horot IV; Tkachenko MM
Probl Radiac Med Radiobiol; 2017 Dec; 22():184-201. PubMed ID: 29286505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
